Promega introduces custom assay services for biologics and small molecule drug discovery
By Dr Neal Cosby, Promega Corp

The economics of contemporary drug discovery are forcing changes upon the industry at an alarming rate. Even academic and government laboratories are getting into the drug discovery game. Many of the larger pharmaceutical companies at least are turning to academia for their expertise in target identification and target validation.

Please click on the file in the right hand panel to download this Application Note.